DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection

PloS One
Neha DalmiaAlistair J Ramsay

Abstract

There is an urgent need for effective prophylactic measures against Mycobacterium tuberculosis (Mtb) infection, particularly given the highly variable efficacy of Bacille Calmette-Guerin (BCG), the only licensed vaccine against tuberculosis (TB). Most studies indicate that cell-mediated immune responses involving both CD4+ and CD8+ T cells are necessary for effective immunity against Mtb. Genetic vaccination induces humoral and cellular immune responses, including CD4+ and CD8+ T-cell responses, against a variety of bacterial, viral, parasitic and tumor antigens, and this strategy may therefore hold promise for the development of more effective TB vaccines. Novel formulations and delivery strategies to improve the immunogenicity of DNA-based vaccines have recently been evaluated, and have shown varying degrees of success. In the present study, we evaluated DNA-launched Venezuelan equine encephalitis replicons (Vrep) encoding a novel fusion of the mycobacterial antigens α-crystallin (Acr) and antigen 85B (Ag85B), termed Vrep-Acr/Ag85B, for their immunogenicity and protective efficacy in a murine model of pulmonary TB. Vrep-Acr/Ag85B generated antigen-specific CD4+ and CD8+ T cell responses that persisted for at least 10 wk post-...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J L FlynnB R Bloom
Dec 1, 1993·The Journal of Experimental Medicine·A M CooperI M Orme
Mar 2, 1994·JAMA : the Journal of the American Medical Association·G A ColditzF Mosteller
Jun 13, 1998·Nature Biotechnology·P BerglundP Liljeström
Jan 7, 2000·Journal of Virology·G H MacDonald, R E Johnston
Mar 31, 2000·Immunology Today·I A Ramshaw, A J Ramsay
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M DupuisD M McDonald
Sep 7, 2001·Annual Review of Microbiology·L G Wayne, C D Sohaskey
Dec 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lanbo ShiRobert J North
Jan 22, 2003·Immunology and Cell Biology·Warwick J Britton, Umaimainthan Palendira
Jul 4, 2003·The Journal of Clinical Investigation·Wolfgang W Leitner, Nicholas P Restifo
Dec 24, 2003·International Reviews of Immunology·Mei-Ling Li, Victor Stollar
Apr 16, 2004·Clinical Microbiology Reviews·Malavika GiriDavid B Weiner
Jul 2, 2004·Nature Biotechnology·Kendall Powell
Feb 16, 2005·Nature·Oliver SchulzCaetano Reis e Sousa
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Joseph M ThompsonRobert E Johnston
Apr 20, 2006·Trends in Molecular Medicine·Jeffrey B UlmerMargaret A Liu
Mar 8, 2008·Expert Review of Vaccines·Shan LuJill M Grimes-Serrano
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emily K ForbesElma Z Tchilian
Nov 13, 2008·Expert Reviews in Molecular Medicine·Gregory J AtkinsBrian J Sheahan
Feb 19, 2009·European Journal of Immunology·Jayne S SutherlandMartin O C Ota

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
dissection
FCS
Assay

Software Mentioned

SPICEv4
GenScript
PESTLEv1
Java Codon Optimization Tool
FlowJo

Related Concepts

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.